Literature DB >> 16327766

Opinion: the origin of the cancer stem cell: current controversies and new insights.

Rolf Bjerkvig1, Berit B Tysnes, Karen S Aboody, Joseph Najbauer, A J A Terzis.   

Abstract

Most tumours are derived from a single cell that is transformed into a cancer-initiating cell (cancer stem cell) that has the capacity to proliferate and form tumours in vivo. However, the origin of the cancer stem cell remains elusive. Interestingly, during development and tissue repair the fusion of genetic and cytoplasmic material between cells of different origins is an important physiological process. Such cell fusion and horizontal gene-transfer events have also been linked to several fundamental features of cancer and could be important in the development of the cancer stem cell.

Entities:  

Mesh:

Year:  2005        PMID: 16327766     DOI: 10.1038/nrc1740

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  190 in total

Review 1.  EpCAM and its potential role in tumor-initiating cells.

Authors:  Sannia Imrich; Matthias Hachmeister; Olivier Gires
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

Review 2.  NF-κB signaling in cancer stem cells: a promising therapeutic target?

Authors:  K Vazquez-Santillan; J Melendez-Zajgla; L Jimenez-Hernandez; G Martínez-Ruiz; V Maldonado
Journal:  Cell Oncol (Dordr)       Date:  2015-08-29       Impact factor: 6.730

3.  Rb is dispensable for self-renewal and multilineage differentiation of adult hematopoietic stem cells.

Authors:  Carl R Walkley; Stuart H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

Review 4.  Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities.

Authors:  Ali Hassanzadeh; Heshu Sulaiman Rahman; Alexander Markov; Judi Januadi Endjun; Angelina Olegovna Zekiy; Max Stanley Chartrand; Nasrin Beheshtkhoo; Mohammad Amin Jadidi Kouhbanani; Faroogh Marofi; Marzieh Nikoo; Mostafa Jarahian
Journal:  Stem Cell Res Ther       Date:  2021-05-21       Impact factor: 6.832

Review 5.  Magnetic resonance imaging characteristics of glioblastoma multiforme: implications for understanding glioma ontogeny.

Authors:  Leif-Erik Bohman; Kristin R Swanson; Julia L Moore; Russ Rockne; Christopher Mandigo; Todd Hankinson; Marcela Assanah; Peter Canoll; Jeffrey N Bruce
Journal:  Neurosurgery       Date:  2010-11       Impact factor: 4.654

6.  Modulation of potassium channel function confers a hyperproliferative invasive phenotype on embryonic stem cells.

Authors:  Junji Morokuma; Douglas Blackiston; Dany S Adams; Guiscard Seebohm; Barry Trimmer; Michael Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-17       Impact factor: 11.205

7.  Hepatitis B virus X (HBx) play an anti-apoptosis role in hepatic progenitor cells by activating Wnt/β-catenin pathway.

Authors:  Lihong Shen; Xifeng Zhang; Daixi Hu; Tao Feng; Hongli Li; Yongliang Lu; Jiayi Huang
Journal:  Mol Cell Biochem       Date:  2013-08-10       Impact factor: 3.396

8.  Expression of Cancer Stem Cell Biomarkers in Human Head and Neck Carcinomas: a Systematic Review.

Authors:  Raissa Borges Curtarelli; Jussara Maria Gonçalves; Luciane Geanini Pena Dos Santos; Maria Gorete Savi; Jacques Eduardo Nör; Luis André Mendonça Mezzomo; Mabel Mariela Rodríguez Cordeiro
Journal:  Stem Cell Rev Rep       Date:  2018-12       Impact factor: 5.739

9.  Cancer stem cell hypothesis: a brief summary and two proposals.

Authors:  Shuhua Zheng; Longzuo Xin; Aihua Liang; Yuejun Fu
Journal:  Cytotechnology       Date:  2012-12-19       Impact factor: 2.058

10.  Stabilized beta-catenin functions through TCF/LEF proteins and the Notch/RBP-Jkappa complex to promote proliferation and suppress differentiation of neural precursor cells.

Authors:  Takeshi Shimizu; Tetsushi Kagawa; Toshihiro Inoue; Aya Nonaka; Shinji Takada; Hiroyuki Aburatani; Tetsuya Taga
Journal:  Mol Cell Biol       Date:  2008-10-13       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.